Summary

The global metabolic testing market is projected to be valued at US$ 720 Mn in 2025, and it is expected to reach approximately US$ 1,260 Mn by 2032, expanding at a CAGR of 8.32% during the forecast period from 2025 to 2032. Increasing emphasis on preventive healthcare, rising cases of obesity and metabolic disorders, and growing interest in fitness and performance monitoring are collectively driving demand. The market is also benefiting from technological advancements and broader accessibility of portable and software-integrated diagnostic tools.

Metabolic Testing Market – Report Scope:

The metabolic testing market comprises diagnostic systems and technologies used to evaluate metabolic functions like oxygen consumption (VO2 max), resting metabolic rate (RMR), and body composition. These tools are essential for clinical diagnostics, athletic performance testing, and health risk assessments. With growing awareness around personalized health and wellness, these systems are gaining wider adoption across hospitals, laboratories, sports training centers, and fitness facilities. Innovations in compact and mobile testing devices have further broadened the application base across regions and sectors.

Market Growth Drivers:

The rise in lifestyle-related conditions such as diabetes, obesity, and cardiovascular disease is a primary driver for metabolic testing. An increasing focus on early diagnosis and preventive care has led to greater integration of these tools in clinical settings. The growing use of VO2 and RMR analysis in sports medicine and fitness training also supports market expansion. Technological innovation, including software integration, real-time data analytics, and wearable sensors, enhances diagnostic precision and user convenience, making these solutions more appealing to a broader customer base.

Market Restraints:

High initial costs associated with metabolic testing equipment remain a key barrier, particularly for smaller healthcare providers and fitness centers. The requirement for trained personnel to operate complex systems and interpret results further restricts widespread adoption. In several regions, limited reimbursement for metabolic diagnostics adds financial burden, discouraging uptake. Moreover, lack of awareness and inconsistent access to healthcare infrastructure in low- and middle-income countries may hamper market growth during the forecast period.

Market Opportunities:

Emerging economies present substantial growth opportunities as awareness regarding health and fitness rises, and healthcare infrastructure improves. The increasing popularity of personalized health and performance optimization is fostering demand for home-based and wearable metabolic monitors. Integration of AI and cloud-based platforms for real-time monitoring and diagnostics is opening up new avenues for product innovation. Companies focusing on lightweight, user-friendly, and affordable systems are well-positioned to capitalize on growing demand from gyms, sports institutes, and remote care settings.

Regional Outlook:

North America holds the largest share of the global metabolic testing market, owing to its well-established healthcare infrastructure, strong presence of leading manufacturers, and high prevalence of obesity and sedentary lifestyles. Europe follows closely, with rising investments in wellness programs and diagnostics. Asia Pacific is expected to witness the fastest growth, supported by increasing health awareness, growing fitness trends, and expanding healthcare infrastructure in countries such as China, India, and Japan. Latin America and the Middle East & Africa are expected to offer moderate growth, driven by gradual improvements in healthcare accessibility and diagnostic technology penetration.

Leading Companies:

Prominent players in the metabolic testing market, including CareFusion Corporation, GE Healthcare, and MGC Diagnostics Corporation, are focusing on developing innovative, compact, and integrated systems for both clinical and non-clinical use. Strategic partnerships, product launches, and expansion into emerging markets are key strategies being adopted to strengthen market presence. Investments in AI-driven diagnostics and portable testing solutions remain a central area of focus for gaining competitive advantage.

Companies Covered in This Report:

• CareFusion Corporation

• General Electric Company

• Geratherm Medical AG

• MGC Diagnostics Corporation

• OSI Systems, Inc.

• AEI Technologies, Inc.

• Cortex Biophysik GmbH

• COSMED

• Korr Medical Technologies, Inc.

• Microlife Medical Home Solutions, Inc.

• Parvo Medics, Inc.


Market Segmentation:

By Product:

• CPET Systems

• Metabolic Carts

• Body Consumption Analyzers

• ECGs/EKGs Attachable to CPET Systems

• Software

By Application:

• Lifestyle Diseases

• Critical Care

• Human Performance Testing

• Dysmetabolic Syndrome X

• Metabolic Disorders

• Other Applications

By Technology:

• VO2 Max Analysis

• RMR Analysis

• Body Composition Analysis

By End User:

• Hospitals

• Laboratories

• Sports Training Centers

• Gyms

• Other End Users

By Region:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Metabolic Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Metabolic Testing Market Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Metabolic Testing Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Metabolic Testing Market Outlook, 2019-2032
5.1. Global Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. CPET Systems
5.1.1.2. Metabolic Carts
5.1.1.3. Body Consumption Analyzers
5.1.1.4. ECGs/EKGs Attachable to CPET Systems
5.1.1.5. Software
5.2. Global Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Lifestyle Diseases
5.2.1.2. Critical Care
5.2.1.3. Human Performance Testing
5.2.1.4. Dysmetabolic Syndrome X
5.2.1.5. Metabolic Disorders
5.2.1.6. Other Applications
5.3. Global Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. VO2 Max Analysis
5.3.1.2. RMR Analysis
5.3.1.3. Body Composition Analysis
5.4. Global Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Laboratories
5.4.1.3. Sports Training Centers
5.4.1.4. Gyms
5.4.1.5. Other End Users
5.5. Global Metabolic Testing Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2019-2032
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Metabolic Testing Market Outlook, 2019-2032
6.1. North America Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. CPET Systems
6.1.1.2. Metabolic Carts
6.1.1.3. Body Consumption Analyzers
6.1.1.4. ECGs/EKGs Attachable to CPET Systems
6.1.1.5. Software
6.2. North America Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Lifestyle Diseases
6.2.1.2. Critical Care
6.2.1.3. Human Performance Testing
6.2.1.4. Dysmetabolic Syndrome X
6.2.1.5. Metabolic Disorders
6.2.1.6. Other Applications
6.3. North America Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. VO2 Max Analysis
6.3.1.2. RMR Analysis
6.3.1.3. Body Composition Analysis
6.4. North America Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Laboratories
6.4.1.3. Sports Training Centers
6.4.1.4. Gyms
6.4.1.5. Other End Users
6.5. North America Metabolic Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1. Key Highlights
6.5.1.1. U.S. Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.2. U.S. Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.3. U.S. Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.4. U.S. Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.5. Canada Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.6. Canada Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.7. Canada Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.1.8. Canada Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Metabolic Testing Market Outlook, 2019-2032
7.1. Europe Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. CPET Systems
7.1.1.2. Metabolic Carts
7.1.1.3. Body Consumption Analyzers
7.1.1.4. ECGs/EKGs Attachable to CPET Systems
7.1.1.5. Software
7.2. Europe Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Lifestyle Diseases
7.2.1.2. Critical Care
7.2.1.3. Human Performance Testing
7.2.1.4. Dysmetabolic Syndrome X
7.2.1.5. Metabolic Disorders
7.2.1.6. Other Applications
7.3. Europe Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. VO2 Max Analysis
7.3.1.2. RMR Analysis
7.3.1.3. Body Composition Analysis
7.4. Europe Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Laboratories
7.4.1.3. Sports Training Centers
7.4.1.4. Gyms
7.4.1.5. Other End Users
7.5. Europe Metabolic Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Germany Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.2. Germany Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.3. Germany Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.4. Germany Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.5. U.K. Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.6. U.K. Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.7. U.K. Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.8. U.K. Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.9. France Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.10. France Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.11. France Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.12. France Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.13. Italy Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.14. Italy Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.15. Italy Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.16. Italy Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.17. Turkey Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.18. Turkey Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.19. Turkey Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.20. Turkey Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.21. Russia Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.22. Russia Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.23. Russia Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.24. Russia Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.25. Rest of Europe Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.26. Rest of Europe Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.27. Rest of Europe Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.1.28. Rest of Europe Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Metabolic Testing Market Outlook, 2019-2032
8.1. Asia Pacific Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. CPET Systems
8.1.1.2. Metabolic Carts
8.1.1.3. Body Consumption Analyzers
8.1.1.4. ECGs/EKGs Attachable to CPET Systems
8.1.1.5. Software
8.2. Asia Pacific Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Lifestyle Diseases
8.2.1.2. Critical Care
8.2.1.3. Human Performance Testing
8.2.1.4. Dysmetabolic Syndrome X
8.2.1.5. Metabolic Disorders
8.2.1.6. Other Applications
8.3. Asia Pacific Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. VO2 Max Analysis
8.3.1.2. RMR Analysis
8.3.1.3. Body Composition Analysis
8.4. Asia Pacific Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Laboratories
8.4.1.3. Sports Training Centers
8.4.1.4. Gyms
8.4.1.5. Other End Users
8.5. Asia Pacific Metabolic Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1. Key Highlights
8.5.1.1. China Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.2. China Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.3. China Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.4. China Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.5. Japan Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.6. Japan Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.7. Japan Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.8. Japan Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.9. South Korea Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.10. South Korea Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.11. South Korea Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.12. South Korea Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.13. India Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.14. India Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.15. India Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.16. India Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.17. Southeast Asia Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.18. Southeast Asia Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.19. Southeast Asia Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.20. Southeast Asia Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.21. Rest of Asia Pacific Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.22. Rest of Asia Pacific Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.23. Rest of Asia Pacific Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.1.24. Rest of Asia Pacific Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Metabolic Testing Market Outlook, 2019-2032
9.1. Latin America Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. CPET Systems
9.1.1.2. Metabolic Carts
9.1.1.3. Body Consumption Analyzers
9.1.1.4. ECGs/EKGs Attachable to CPET Systems
9.1.1.5. Software
9.2. Latin America Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.2.1. Key Highlights
9.2.1.1. Lifestyle Diseases
9.2.1.2. Critical Care
9.2.1.3. Human Performance Testing
9.2.1.4. Dysmetabolic Syndrome X
9.2.1.5. Metabolic Disorders
9.2.1.6. Other Applications
9.3. Latin America Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. VO2 Max Analysis
9.3.1.2. RMR Analysis
9.3.1.3. Body Composition Analysis
9.4. Latin America Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Laboratories
9.4.1.3. Sports Training Centers
9.4.1.4. Gyms
9.4.1.5. Other End Users
9.5. Latin America Metabolic Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1. Key Highlights
9.5.1.1. Brazil Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.2. Brazil Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.3. Brazil Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.4. Brazil Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.5. Mexico Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.6. Mexico Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.7. Mexico Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.8. Mexico Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.9. Argentina Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.10. Argentina Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.11. Argentina Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.12. Argentina Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.13. Rest of Latin America Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.14. Rest of Latin America Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.15. Rest of Latin America Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.1.16. Rest of Latin America Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Metabolic Testing Market Outlook, 2019-2032
10.1. Middle East & Africa Metabolic Testing Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. CPET Systems
10.1.1.2. Metabolic Carts
10.1.1.3. Body Consumption Analyzers
10.1.1.4. ECGs/EKGs Attachable to CPET Systems
10.1.1.5. Software
10.2. Middle East & Africa Metabolic Testing Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Lifestyle Diseases
10.2.1.2. Critical Care
10.2.1.3. Human Performance Testing
10.2.1.4. Dysmetabolic Syndrome X
10.2.1.5. Metabolic Disorders
10.2.1.6. Other Applications
10.3. Middle East & Africa Metabolic Testing Market Outlook, by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. VO2 Max Analysis
10.3.1.2. RMR Analysis
10.3.1.3. Body Composition Analysis
10.4. Middle East & Africa Metabolic Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Laboratories
10.4.1.3. Sports Training Centers
10.4.1.4. Gyms
10.4.1.5. Other End Users
10.5. Middle East & Africa Metabolic Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1. Key Highlights
10.5.1.1. GCC Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.2. GCC Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.3. GCC Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.4. GCC Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.5. South Africa Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.6. South Africa Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.7. South Africa Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.8. South Africa Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.9. Egypt Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.10. Egypt Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.11. Egypt Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.12. Egypt Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.13. Nigeria Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.14. Nigeria Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.15. Nigeria Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.16. Nigeria Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.17. Rest of Middle East & Africa Metabolic Testing Market by Product, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.18. Rest of Middle East & Africa Metabolic Testing Market by Application, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.19. Rest of Middle East & Africa Metabolic Testing Market by Technology, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.1.20. Rest of Middle East & Africa Metabolic Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2032
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Technology vs Application Heatmap
11.2. Company Market Share Analysis, 2024
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. CareFusion Corporation
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. General Electric Company
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Geratherm Medical AG
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. MGC Diagnostics Corporation
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. OSI Systems, Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. AEI Technologies, Inc.
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Cortex Biophysik GmbH
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. COSMED
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Korr Medical Technologies, Inc.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. Microlife Medical Home Solutions, Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Parvo Medics, Inc.
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations